Pienta KJ - Search Results

1

Circulating tumour cells as biomarkers of prostate, bladder, and kidney cancer.

Gorin MA, Verdone JE, van der Toom E, Bivalacqua TJ, Allaf ME, Pienta KJ. Gorin MA, et al. Among authors: pienta kj. Nat Rev Urol. 2017 Feb;14(2):90-97. doi: 10.1038/nrurol.2016.224. Epub 2016 Nov 22. Nat Rev Urol. 2017. PMID: 27872478 Review.

2

The effects of basic fibroblast growth factor and suramin on cell motility and growth of rat prostate cancer cells.

Pienta KJ, Isaacs WB, Vindivich D, Coffey DS. Pienta KJ, et al. J Urol. 1991 Jan;145(1):199-202. doi: 10.1016/s0022-5347(17)38291-5. J Urol. 1991. PMID: 1984091 Free article.

3

Preliminary study of immunomagnetic quantification of circulating tumor cells in patients with advanced disease.

Chen BT, Loberg RD, Neeley CK, O'Hara SM, Gross S, Doyle G, Dunn RL, Kalikin LM, Pienta KJ. Chen BT, et al. Among authors: pienta kj. Urology. 2005 Mar;65(3):616-21. doi: 10.1016/j.urology.2004.10.053. Urology. 2005. PMID: 15780403

4

Circulating fibroblast-like cells in men with metastatic prostate cancer.

Jones ML, Siddiqui J, Pienta KJ, Getzenberg RH. Jones ML, et al. Among authors: pienta kj. Prostate. 2013 Jan;73(2):176-81. doi: 10.1002/pros.22553. Epub 2012 Jun 21. Prostate. 2013. PMID: 22718300 Free PMC article.

5

Words of wisdom: re: androgen receptor splice variants mediate enzalutamide resistance in castration-resistant prostate cancer cell lines.

Luo J, Pienta KJ. Luo J, et al. Among authors: pienta kj. Eur Urol. 2013 Aug;64(2):339-40. doi: 10.1016/j.eururo.2013.05.012. Eur Urol. 2013. PMID: 23830228 No abstract available.

6

Beyond the androgen receptor: new approaches to treating metastatic prostate cancer. Report of the 2013 Prouts Neck Prostate Cancer Meeting.

Pienta KJ, Walia G, Simons JW, Soule HR. Pienta KJ, et al. Prostate. 2014 Feb;74(3):314-20. doi: 10.1002/pros.22753. Prostate. 2014. PMID: 24249419 Free PMC article.

7

The presence of androgen receptor elements regulates ZEB1 expression in the absence of androgen receptor.

Mooney SM, Parsana P, Hernandez JR, Liu X, Verdone JE, Torga G, Harberg CA, Pienta KJ. Mooney SM, et al. Among authors: pienta kj. J Cell Biochem. 2015 Jan;116(1):115-23. doi: 10.1002/jcb.24948. J Cell Biochem. 2015. PMID: 25160502 Free PMC article.

8

Epithelial-mesenchymal transition in prostate cancer is associated with quantifiable changes in nuclear structure.

Verdone JE, Parsana P, Veltri RW, Pienta KJ. Verdone JE, et al. Among authors: pienta kj. Prostate. 2015 Feb;75(2):218-24. doi: 10.1002/pros.22908. Epub 2014 Oct 18. Prostate. 2015. PMID: 25327565 Free PMC article.

9

Glycolysis is the primary bioenergetic pathway for cell motility and cytoskeletal remodeling in human prostate and breast cancer cells.

Shiraishi T, Verdone JE, Huang J, Kahlert UD, Hernandez JR, Torga G, Zarif JC, Epstein T, Gatenby R, McCartney A, Elisseeff JH, Mooney SM, An SS, Pienta KJ. Shiraishi T, et al. Among authors: pienta kj. Oncotarget. 2015 Jan 1;6(1):130-43. doi: 10.18632/oncotarget.2766. Oncotarget. 2015. PMID: 25426557 Free PMC article.

10

Magnetic resonance-invisible versus magnetic resonance-visible prostate cancer in active surveillance: a preliminary report on disease outcomes.

Dianat SS, Carter HB, Pienta KJ, Schaeffer EM, Landis PK, Epstein JI, Trock BJ, Macura KJ. Dianat SS, et al. Among authors: pienta kj. Urology. 2015 Jan;85(1):147-53. doi: 10.1016/j.urology.2014.06.085. Epub 2014 Oct 16. Urology. 2015. PMID: 25440986

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

655 results

Search Page

Filters